Image

Comparative Effects of Coherent Breathing and Regular Paced Breathing on Dyspnea and Pulmonary Function in Patients With Chronic Obstructive Pulmonary Disease

Comparative Effects of Coherent Breathing and Regular Paced Breathing on Dyspnea and Pulmonary Function in Patients With Chronic Obstructive Pulmonary Disease

Recruiting
40-75 years
All
Phase N/A

Powered by AI

Overview

Chronic Obstructive Pulmonary Disease (COPD) is an inflammatory condition of airways characterized by recurrent episodes of coughing, respiratory muscle weakness, lung hyperinflation and air trapping which ultimately leads to dyspnea, impaired pulmonary function and reduced quality of life.

Non- pharmacological approaches, particularly breathing retraining techniques, have gained recognition as complementary strategies for optimizing COPD management by improving overall functional status and exercise tolerance in the patients.

Description

Chronic Obstructive Pulmonary Disease is a progressive lung condition which is characterized by persistent airflow limitation that gradually worsens over time.

The alveolar air sacs become damaged, and bronchial tubes narrow due to inflammation and increased mucus production. Theses structural and inflammatory changes significantly impair the airflow, reduce the efficiency of gas exchage and make the breathing dfficult.

Breathing exercises are an important component of non-pharmacological management in patients with COPD.

Among different breathing techniques, coherent breathing and regular paced breathing have been used to promote controlled respiratory patterns and improve breathing efficiency.

A total of 46 participants will be allocated into two groups. Group A will perform Coherent breathing and Group B will perform Regular Paced breathing along with pharmacological management.

The objective of this study is to compare the effects of Coherent Breathing versus Regular Paced Breathing on dyspnea, pulmonary function and quality of life in patients with COPD.

Eligibility

Inclusion Criteria:

  • Age between 40-75 years.
  • Both genders (male and females).
  • Diagnosed COPD mild to moderate stage according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification:

Mild: FEV1 ≥ 80% predicted Moderate: FEV1 fall between 50-79%

  • Diagnosed with COPD for at least 6 months prior to enrollment in study
  • Resting SpO₂ ≥ 90% on room air

Exclusion Criteria:

  • Severe and very severe stage of COPD according to GOLD classification
  • Patients having acute exacerbation of COPD with in the last 4 weeks
  • Hemodnamically unstable patients
  • Current smokers (active smoking or individuals using any tobacco product within the 6 months)
  • Other sgnificant respiratory diseases (e.g., asthma, bronchiectasis, ILD, active tuberculosis)
  • Patients unable to follow commands/instructions
  • Patients currently participating in any other structured pulmonary rehabilitation or breathing intervention program

Study details
    Pulmonary Disease
    Chronic Obstructive (COPD)

NCT07875036

Foundation University Islamabad

21 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.